Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

Pitt Develops Biodegradable Artery Graft to Enhance Bypass Surgeries

June 25, 2012 By AxoGen, Inc.

With the University of Pittsburgh’s development of a
cell-free, biodegradable artery graft comes a potentially transformative change
in coronary artery bypass surgeries: Within 90 days after surgery, the patient
will have a regenerated artery with no trace of synthetic graft materials left
in the body.

Research published online June 24 in Nature Medicine
highlights work led by principal investigator Yadong Wang, a professor in
Pitt’s Swanson School of Engineering and the School of Medicine’s Department of
Surgery, who designed grafts that fully harness the body’s regenerative
capacity. This new approach is a philosophical shift from the predominant
cell-centered approaches in tissue engineering of blood vessels.

“The host site, the artery in this case, is an excellent
source of cells and provides a very efficient growth environment,” said Wang.
“This is what inspired us to skip the cell culture altogether and create these
cell-free synthetic grafts.”

Wang and fellow researchers Wei Wu, a former Pitt postdoctoral
associate (now a postdoctoral associate at Yale University), and Robert Allen,
a Pitt PhD student in bioengineering, designed the graft with three properties
in mind. First, they chose a graft material—an elastic polymer called PGS—that
is resorbed quickly by the body. Then they examined graft porosity and selected
parameters that allow immediate cell infiltration. Wang’s team borrowed a
procedure developed by another team of Pitt researchers—David Vorp, professor
of bioengineering and surgery, and William R. Wagner, interim director of the
University’s McGowan Institute for Regenerative Medicine and a professor of
surgery, bioengineering, and chemical engineering—wrapping the vascular graft
with a fibrous sheath to trap the cells. Finally, Wang and his fellow
researchers wanted a coating for the grafts that would reduces blood clotting
and bind many growth factors, so they used heparin, a molecule that does just
that.

“The results were porous grafts that are suturable,” said
Wang. “And the rapid remodeling of the grafts led to strong and compliant new
arteries. The extent of the changes in the grafts that occurred in just 90 days
was remarkable.”

Wang and his colleagues made grafts as small as 1 mm in
diameter and monitored the graft’s transformation in vivo for three months.
Because the graft was highly porous, cells were easily able to penetrate the
graft wall, and mononuclear cells occupied many of the pores within three days.
Within 14 days, smooth muscle cells—an important blood vessel builder—appeared.
At 28 days, cells were distributed more evenly throughout the graft. At 90
days, most inflammatory cells were gone, which correlated with the
disappearance of the graft materials. The artery was regenerated in situ and
pulsed in sync with the host. Furthermore, the composition and properties of
the new arteries are nearly the same as native arteries.

“This report is the first that shows a nearly complete
transformation of a synthetic plastic tube to a new host artery with excellent
integration within three months,” said Wang. “Most likely, the amount of time
it takes to regenerate an artery can be further shortened as we refine the
system.”

Current approaches toward tissue-engineered arteries require
a long production cycle because of the required cell culture steps. The newly
developed graft is made in a few days, stores in a dry pouch at ambient
temperature, and is readily available off the shelf. The ease of use and
storage are similar to the conventional Dacron® grafts.

The project was funded by the National Heart, Lung, and
Blood Institute, part of the National Institutes of Health.

Related Articles Read More >

UMN artificial blood vessel clinical trial
Minnesota researchers awarded $3.7M grant for artificial, bioengineered blood vessel clinical trial
CeQur Simplicity
CeQur is launching a discreet, convenient ‘wearable insulin pen’
Blackrock's Utah array is a miniature array of electrodes for sensing brain signals
Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
Engineer inspecting artificial hip joint parts in quality control department in orthopaedic factory
Deburring and finishing for beautiful, functional medical devices

DeviceTalks Weekly.

August 5, 2022
DTW Medtronic's Greg Smith lays out supply chain strategies
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • Subscribe to Print Magazine
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech